These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21902538)

  • 1. Gene therapy for traumatic central nervous system injury and stroke using an engineered zinc finger protein that upregulates VEGF-A.
    D'Onofrio PM; Thayapararajah M; Lysko MD; Magharious M; Spratt SK; Lee G; Ando D; Surosky R; Fehlings MG; Koeberle PD
    J Neurotrauma; 2011 Sep; 28(9):1863-79. PubMed ID: 21902538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An engineered transcription factor which activates VEGF-A enhances recovery after spinal cord injury.
    Liu Y; Figley S; Spratt SK; Lee G; Ando D; Surosky R; Fehlings MG
    Neurobiol Dis; 2010 Feb; 37(2):384-93. PubMed ID: 19879362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of traumatic brain injury using zinc-finger protein gene therapy targeting VEGF-A.
    Siddiq I; Park E; Liu E; Spratt SK; Surosky R; Lee G; Ando D; Giedlin M; Hare GM; Fehlings MG; Baker AJ
    J Neurotrauma; 2012 Nov; 29(17):2647-59. PubMed ID: 23016562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered zinc finger-activating vascular endothelial growth factor transcription factor plasmid DNA induces therapeutic angiogenesis in rabbits with hindlimb ischemia.
    Dai Q; Huang J; Klitzman B; Dong C; Goldschmidt-Clermont PJ; March KL; Rokovich J; Johnstone B; Rebar EJ; Spratt SK; Case CC; Kontos CD; Annex BH
    Circulation; 2004 Oct; 110(16):2467-75. PubMed ID: 15477407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An engineered vascular endothelial growth factor-activating transcription factor induces therapeutic angiogenesis in ApoE knockout mice with hindlimb ischemia.
    Xie D; Li Y; Reed EA; Odronic SI; Kontos CD; Annex BH
    J Vasc Surg; 2006 Jul; 44(1):166-75. PubMed ID: 16753278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene transfer of an engineered transcription factor promoting expression of VEGF-A protects against experimental diabetic neuropathy.
    Price SA; Dent C; Duran-Jimenez B; Liang Y; Zhang L; Rebar EJ; Case CC; Gregory PD; Martin TJ; Spratt SK; Tomlinson DR
    Diabetes; 2006 Jun; 55(6):1847-54. PubMed ID: 16731852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.
    Li Y; Hazarika S; Xie D; Pippen AM; Kontos CD; Annex BH
    Diabetes; 2007 Mar; 56(3):656-65. PubMed ID: 17327433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AAV-mediated expression of CNTF promotes long-term survival and regeneration of adult rat retinal ganglion cells.
    Leaver SG; Cui Q; Plant GW; Arulpragasam A; Hisheh S; Verhaagen J; Harvey AR
    Gene Ther; 2006 Sep; 13(18):1328-41. PubMed ID: 16708079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy and transplantation in the retinofugal pathway.
    Harvey AR; Hellström M; Rodger J
    Prog Brain Res; 2009; 175():151-61. PubMed ID: 19660654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An engineered VEGF-activating zinc finger protein transcription factor improves blood flow and limb salvage in advanced-age mice.
    Yu J; Lei L; Liang Y; Hinh L; Hickey RP; Huang Y; Liu D; Yeh JL; Rebar E; Case C; Spratt K; Sessa WC; Giordano FJ
    FASEB J; 2006 Mar; 20(3):479-81. PubMed ID: 16423874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant adeno-associated virus serotype 1-vascular endothelial growth factor promotes neurogenesis and neuromigration in the subventricular zone and rescues neuronal function in ischemic rats.
    Li SF; Sun YB; Meng QH; Li SR; Yao WC; Hu GJ; Li ZJ; Wang RZ
    Neurosurgery; 2009 Oct; 65(4):771-9; discussion 779. PubMed ID: 19834383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of endogenous gene expression using small molecule-controlled engineered zinc-finger protein transcription factors.
    Dent CL; Lau G; Drake EA; Yoon A; Case CC; Gregory PD
    Gene Ther; 2007 Sep; 14(18):1362-9. PubMed ID: 17637799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repression of vascular endothelial growth factor A in glioblastoma cells using engineered zinc finger transcription factors.
    Snowden AW; Zhang L; Urnov F; Dent C; Jouvenot Y; Zhong X; Rebar EJ; Jamieson AC; Zhang HS; Tan S; Case CC; Pabo CO; Wolffe AP; Gregory PD
    Cancer Res; 2003 Dec; 63(24):8968-76. PubMed ID: 14695215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed administration of a bio-engineered zinc-finger VEGF-A gene therapy is neuroprotective and attenuates allodynia following traumatic spinal cord injury.
    Figley SA; Liu Y; Karadimas SK; Satkunendrarajah K; Fettes P; Spratt SK; Lee G; Ando D; Surosky R; Giedlin M; Fehlings MG
    PLoS One; 2014; 9(5):e96137. PubMed ID: 24846143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative iTRAQ analysis of retinal ganglion cell degeneration after optic nerve crush.
    Magharious M; D'Onofrio PM; Hollander A; Zhu P; Chen J; Koeberle PD
    J Proteome Res; 2011 Aug; 10(8):3344-62. PubMed ID: 21627321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperative effects of bcl-2 and AAV-mediated expression of CNTF on retinal ganglion cell survival and axonal regeneration in adult transgenic mice.
    Leaver SG; Cui Q; Bernard O; Harvey AR
    Eur J Neurosci; 2006 Dec; 24(12):3323-32. PubMed ID: 17229081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adenovirus-mediated vascular endothelial growth factor165 gene therapy in treatment of hypoxic-ischemic brain damage: experiment with rats].
    Zheng XR; Zhang SS; Yin F; Yang YJ; Zhong L; Wang X; Yu XH
    Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(2):128-32. PubMed ID: 19489278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved survival of ischemic cutaneous and musculocutaneous flaps after vascular endothelial growth factor gene transfer using adeno-associated virus vectors.
    Zacchigna S; Papa G; Antonini A; Novati F; Moimas S; Carrer A; Arsic N; Zentilin L; Visintini V; Pascone M; Giacca M
    Am J Pathol; 2005 Oct; 167(4):981-91. PubMed ID: 16192634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for optic nerve disease.
    Martin KR; Quigley HA
    Eye (Lond); 2004 Nov; 18(11):1049-55. PubMed ID: 15534589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor gene-transferred bone marrow stromal cells engineered with a herpes simplex virus type 1 vector can improve neurological deficits and reduce infarction volume in rat brain ischemia.
    Miki Y; Nonoguchi N; Ikeda N; Coffin RS; Kuroiwa T; Miyatake S
    Neurosurgery; 2007 Sep; 61(3):586-94; discussion 594-5. PubMed ID: 17881973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.